Cannabis Bioscience International Holdings reported revenue of $0.00B and net income of -$0.00B for the quarter ended Feb 2026, down 25.0% year over year. This income statement covers 14 quarters of results from Nov 2022 through Feb 2026, standardized by Business Quant from the company’s SEC filings.
| Income StatementIncome Statement | Nov2022 | Feb2023 | May2023 | Aug2023 | Nov2023 | Feb2024 | May2024 | Aug2024 | Nov2024 | Feb2025 | May2025 | Aug2025 | Nov2025 | Feb2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||
| Revenue | 0.08M | 0.05M | 0.05M | 0.07M | 0.06M | 0.04M | 0.08M | 0.18M | 0.07M | 0.01M | 0.03M | 0.02M | 0.05M | 0.01M |
| Cost of RevenueCost of Rev | 0.01M | 0.02M | 0.02M | 0.01M | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.00M | 0.01M | 0.01M | 0.00M |
| Gross Profit | 0.08M | 0.03M | 0.03M | 0.06M | 0.05M | 0.02M | 0.07M | 0.17M | 0.07M | 0.00M | 0.03M | 0.02M | 0.04M | 0.01M |
| Operating items | ||||||||||||||
| Selling, General & AdministrativeSG&A | 0.02M | 0.05M | 0.08M | 0.05M | 0.01M | 0.03M | 0.01M | 0.06M | 0.04M | 0.05M | -0.05M | 0.02M | 0.03M | 0.03M |
| Other Operating ExpensesOther Opex | 0.00M | 0.00M | 0.00M | 0.00M | 197.00 | 378.00 | 186.00 | 142.00 | 97.00 | 215.00 | 63.00 | 213.00 | 62.00 | 983.00 |
| Operating ExpensesOpex | 0.26M | 0.31M | 0.31M | 0.24M | 0.14M | 0.18M | 0.10M | 0.27M | 0.13M | 0.12M | 0.17M | 0.09M | 0.14M | 0.10M |
| Operating IncomeOp. Inc | -0.18M | -0.28M | -0.27M | -0.18M | -0.09M | -0.16M | -0.03M | -0.10M | -0.06M | -0.13M | -0.13M | -0.07M | -0.10M | -0.09M |
| Non-operating items | ||||||||||||||
| Non Operating Interest Expenses | 0.04M | 0.04M | 0.00M | 0.01M | 0.03M | 0.05M | 0.10M | 0.00M | 0.01M | 0.02M | 0.10M | 0.02M | 0.02M | 0.01M |
| Other Non Operating IncomeOther Non Op Inc. | 99.00 | 0.01M | 0.02M | 0.01M | 0.03M | 0.03M | 0.00M | 101.00 | ||||||
| Non Operating IncomeNon Op. Inc. | -0.04M | -0.04M | 0.00M | -0.01M | -0.03M | -0.05M | -0.11M | 0.02M | -0.02M | -0.05M | -0.08M | -0.01M | -0.02M | -0.01M |
| Net income details | ||||||||||||||
| EBIT | -0.18M | -0.28M | -0.27M | -0.18M | -0.09M | -0.16M | -0.03M | -0.10M | -0.06M | -0.13M | -0.13M | -0.07M | -0.10M | -0.09M |
| EBT | -0.22M | -0.32M | -0.28M | -0.18M | -0.12M | -0.21M | -0.12M | -0.10M | -0.07M | -0.15M | -0.24M | -0.09M | -0.11M | -0.10M |
| Income After Tax | -0.22M | -0.32M | -0.28M | -0.18M | -0.12M | -0.21M | -0.12M | -0.10M | -0.07M | -0.15M | -0.24M | -0.09M | -0.11M | -0.10M |
| Income from Continuing OperationsIncome (Continuing) | -0.22M | -0.32M | -0.28M | -0.18M | -0.12M | -0.21M | -0.12M | -0.10M | -0.07M | -0.15M | -0.24M | -0.09M | -0.11M | -0.10M |
| Consolidated Net IncomeConsol Net Inc. | -0.22M | -0.32M | -0.28M | -0.18M | -0.12M | -0.21M | -0.12M | -0.10M | -0.07M | -0.15M | -0.24M | -0.09M | -0.11M | -0.10M |
| Income towards Parent CompanyParent Net Inc | -0.22M | -0.32M | -0.28M | -0.18M | -0.12M | -0.21M | -0.14M | -0.08M | -0.08M | -0.18M | -0.21M | -0.08M | -0.12M | -0.10M |
| Net Income towards Common StockholdersNet Income | -0.22M | -0.32M | -0.28M | -0.18M | -0.12M | -0.21M | -0.14M | -0.08M | -0.08M | -0.18M | -0.21M | -0.08M | -0.12M | -0.10M |
| Additional items | ||||||||||||||
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Outstanding | 8,090.50M | 7,858.53M | 9,001.54M | 10,331.75M | 10,331.75M | 10,372.41M | 10,317.61M | 10,458.92M | 10,497.46M | 10,726.47M | 10,716.35M | 11,626.75M | 11,626.75M | 11,626.75M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 8,090.50M | 7,858.53M | 9,001.54M | 10,331.75M | 10,331.75M | 10,372.41M | 10,317.61M | 10,458.92M | 10,497.46M | 10,726.47M | 10,716.35M | 11,626.75M | 11,626.75M | 11,626.75M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 8,846.92M | 7,858.53M | 10,059.68M | 10,331.75M | 10,331.75M | 10,431.75M | 10,431.75M | 10,556.75M | 10,506.75M | 10,931.75M | 11,626.75M | 11,626.75M | 11,626.75M | 11,626.75M |
| Interest ExpensesInt Expense | 0.04M | 0.04M | 0.00M | 0.01M | 0.03M | 0.05M | 0.10M | 0.00M | 0.01M | 0.02M | 0.10M | 0.02M | 0.02M | 0.01M |
Pull Cannabis Bioscience International Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CBIH&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CBIH", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CBIH&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();